Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

A federal commission is calling for $15 billion in new financing to reinforce U.S. biotech leadership amid competition from ...

The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...

The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify ...

Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., and Cipla Ltd. share prices dragged the NSE Nifty Pharma index ...

UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.

The NSE Nifty 50 ended 345.65 points or 1.49% down at 22,904.45, and the BSE Sensex closed 930.67 points or 1.22% lower at 73 ...